Development and validation of a recombinant capsid protein-based ELISA for detection of antibody to porcine circovirus type 2

Res Vet Sci. 2008 Feb;84(1):150-7. doi: 10.1016/j.rvsc.2007.02.007. Epub 2007 Apr 30.

Abstract

Porcine circovirus type 2 (PCV2) has been recently associated with a number of disease syndromes, especially postweaning multisystemic wasting disease (PMWS). Herein, an alternative indirect enzyme-linked immunosorbent assay (ELISA) for detection of PCV2 antibody was developed using nuclear localization signal-truncated capsid protein of PCV2 produced in Escherichia coli (CAP ELISA). This assay was validated by comparison with an indirect immunofluorescence assay (IIF) and a PCV2-based ELISA. The diagnostic sensitivity (DSN), specificity (DSP) and accuracy of the CAP ELISA were 95.3%, 93.9% and 95.1%, compared with IIF on 1080 field serum samples, and 93.3%, 84.2% and 91.1%, compared with the PCV2-based ELISA on 79 field sera, respectively. Cross-reactivity assay showed that this assay was PCV2-specific. Repeatability tests revealed that the coefficients of variation of positive sera within and between runs were less than 15%. This ELISA is simpler to produce and perform, time-saving and suitable for large scale surveys of PCV2 infection at low cost and the evaluation of the efficiency of various vaccines against PCV2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Viral / blood*
  • Capsid Proteins*
  • Circovirus / immunology*
  • Enzyme-Linked Immunosorbent Assay / veterinary*
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Swine
  • Swine Diseases / blood
  • Swine Diseases / diagnosis*
  • Swine Diseases / immunology

Substances

  • Antibodies, Viral
  • Capsid Proteins